Asymchem Labs, a Tianjin CMO, Raises $125 Million in Shenzhen IPO

Asymchem Laboratories (Tianjin) completed a $125 million IPO in Shenzhen. Asymchem is contract manufacturer of APIs, cGMP intermediates and finished drugs, all from a severak manufacturing facilities in China. Most of the proceeds will be used to build its R&D facilities and additional manufacturing facilities in Tianjin, which is also the company's headquarters. More details.... Stock Symbol: (SHZ: OO2821) Share this with colleagues: // //